IMTX SCHEDULE 13G/A: SEC filing
T. Rowe Price Investment Management, Inc.
Filed with the SEC on · accession 0001897612-26-000752
IMTX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -3.4% by the first close after the filing.
Summary of the filing
T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G reporting beneficial ownership of 25,149,155 shares (17.1%) of Immatics N.V. common stock as of September 30, 2026, up from 25,109,257 shares previously reported.
Key details
How IMTX stock reacted
Close before
$6.39
Nov 13, 2026
First close after
-3.44%
$6.17
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for IMTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IMTX?
Click hereFrequently asked questions
What did IMTX file with the SEC on Nov 16, 2026?
IMTX filed a SCHEDULE 13G/A (SEC filing). T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G reporting beneficial ownership of 25,149,155 shares (17.1%) of Immatics N.V. common stock as of September 30, 2026, up from 25,109,257 shares previously reported.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did IMTX stock react to this filing?
IMTX closed at $6.39 before the filing and $6.17 on Nov 16, 2026 (-3.44%).
Other IMTX SEC filings
- SCHEDULE 13G · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 13, 2026
- 6-K · SEC filingNov 10, 2026
- 6-K · Fda approvalOct 26, 2026
- 6-K · SEC filingOct 23, 2026
- SCHEDULE 13D/A · SEC filingAug 27, 2026
- 6-K · Secondary offeringAug 26, 2026
- 424B2 · Secondary offeringAug 25, 2026
- 6-K · SEC filingAug 18, 2026
Get alerts when IMTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days